Abstract:<p>Chemotherapy typically involves the use of specific chemodrugs to inhibit the proliferation of cancer cells, but the frequent emergence of a variety of multidrug‐resistant cancer cells poses a tremendous threat to our combat against cancer. The fundamental causes of multidrug resistance (MDR) have been studied for decades, and can be generally classified into two types: one is associated with the activation of diverse drug efflux pumps, which are responsible for translocating intracellular drug molecules out of the cells; the other is linked with some non‐efflux pump‐related mechanisms, such as antiapoptotic defense, enhanced DNA repair ability, and powerful antioxidant systems. To overcome MDR, intense efforts have been made to develop synergistic therapeutic strategies by introducing MDR inhibitors or combining chemotherapy with other therapeutic modalities, such as phototherapy, gene therapy, and gas therapy, in the hope that the drug‐resistant cells can be sensitized toward chemotherapeutics. In particular, nanotechnology‐based drug delivery platforms have shown the potential to integrate multiple therapeutic agents into one system. In this review, the focus was on the recent development of nanostrategies aiming to enhance the efficiency of chemotherapy and overcome the MDR of cancer in a synergistic manner. Different combinatorial strategies are introduced in detail and the advantages as well as underlying mechanisms of why these strategies can counteract MDR are discussed. This review is expected to shed new light on the design of advanced nanomedicines from the angle of materials and to deepen our understanding of MDR for the development of more effective anticancer strategies.</p><p>This article is categorized under: </p><ul class="plain-list"><li>Nanotechnology Approaches to Biology > Nanoscale Systems in Biology</li><li>Therapeutic Approaches and Drug Discovery > Nanomedicine for Oncologic Disease</li></ul>

Nanoparticle Delivery of Anticancer Drugs Overcomes Multidrug Resistance in Breast Cancer.

Nanomedicine to overcome cancer multidrug resistance.

Progress in the Study of Drug Delivery System Based on Nanoparticles to Overcome Multi-Drug Resistance

Nanomaterials: breaking the bottleneck of breast cancer drug resistance

Advances in Nanobiotechnology-Propelled Multidrug Resistance Circumvention of Cancer

Progress in Research of Nanotherapeutics for Overcoming Multidrug Resistance in Cancer

Nanoparticle-Based Drug Delivery in Cancer Therapy and Its Role in Overcoming Drug Resistance

Applications of Nanoparticle Drug Delivery Systems for the Reversal of Multidrug Resistance in Cancer.

Nano-drug delivery system for the treatment of multidrug-resistant breast cancer: Current status and future perspectives

Nanomedicines for combating multidrug resistance of cancer

Overcoming multidrug resistance in cancer: Recent progress in nanotechnology and new horizons

Nanomedicines for Overcoming Cancer Drug Resistance

The reversal of chemotherapy-induced multidrug resistance by nanomedicine for cancer therapy

Nanomedicine solutions to intricate physiological-pathological barriers and cellular factors of tumor multidrug resistance.

Insight on Multidrug Resistance and Nanomedicine Approaches to Overcome MDR

Nanodelivery Systems as a Novel Strategy to Overcome Treatment Failure of Cancer

Overcoming Cancer Drug Resistance with Nanoparticle Strategies for Key Protein Inhibition

Recent advances in access to overcome cancer drug resistance by nanocarrier drug delivery system

Overcoming Cancer Multi-drug Resistance (MDR): Reasons, mechanisms, nanotherapeutic solutions, and challenges

Multi-modal strategies for overcoming tumor drug resistance: Hypoxia, the Warburg effect, stem cells, and multifunctional nanotechnology

Nanotherapeutic approaches to overcome distinct drug resistance barriers in models of breast cancer